Purdue Pharma L.P.

Track this case

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

March 05, 2020
Purdue Wants Ch. 11 To Hold Opioid Cases At Bay Longer

Bankrupt opioid maker Purdue Pharma LP asked a New York judge late Wednesday to extend a preliminary injunction enacted in its Chapter 11 case that paused thousands of legal actions against the company for its role in the national opioid crisis.
March 02, 2020
Mediators To Form Plan For Purdue Ch. 11 Claims Distribution

A New York bankruptcy judge on Monday approved an order setting up mediation between government and private parties with claims in the Purdue Pharma Chapter 11 case to work out how to divide up the estate's billions of dollars in assets.
February 21, 2020
Purdue Picks Ex-USDA Head As Monitor In Bankruptcy

Purdue Pharma LP announced on Friday that it has tapped former U.S. Secretary of Agriculture Tom Vilsack to monitor compliance with an injunction in the OxyContin maker's ongoing Chapter 11 bankruptcy proceedings.
February 12, 2020
Purdue Wants To Make New Opioid Overdose Drug

Purdue Pharma LP is seeking bankruptcy court approval to begin developing an injectable treatment to reverse overdoses of fentanyl and other opioids, telling the court that time is of the essence in addressing a public health crisis that many have alleged it helped create.
January 24, 2020
Bankruptcy Judge OKs $1.3M Bonus For Purdue CEO

A New York bankruptcy judge ended a monthslong dispute over pay for Purdue Pharmaceutical executives Friday, saying a $1.3 million bonus for the company's CEO is reasonable for the industry.
January 21, 2020
Purdue, Creditors Ask To Keep Stay On Insurance Arbitration

Purdue Pharma and its unsecured creditors are asking a New York bankruptcy judge to deny an insurer's request to allow arbitration over how much product liability coverage it owes the drugmaker to proceed, saying it could severely disrupt Purdue's Chapter 11 case.
December 17, 2019
Sacklers Withdrew $10B From Purdue, Bankruptcy Probe Says

The Sackler family, owners of OxyContin maker Purdue Pharma LP, withdrew $10.4 billion from the company since 2008 as the company faced rising scrutiny over its role in the opioid crisis, according to a report filed Monday in New York bankruptcy court.
December 10, 2019
States Demand Purdue Fight Opioid Crisis With 9-Point Plan

Two dozen states opposed to Purdue Pharma's opioid crisis settlement are asking the bankrupt OxyContin maker to take nine actions to reduce the number of overdose deaths nationwide, saying that in the first half of 2019 alone in Massachusetts, more than two patients prescribed the drug died from overdoses each week.
December 09, 2019
High Court Won't Hear Arizona's Opioid Suit Against Sacklers

The U.S. Supreme Court on Monday declined to hear Arizona's unusual proposed complaint aimed at forcing the Sackler family, the owners of bankrupt OxyContin seller Purdue Pharma LP, to pay back billions of dollars they allegedly raided from the company.
December 04, 2019
Judge Holds Decision On Purdue Pharma CEO Bonus

A New York bankruptcy judge Wednesday said he would approve nearly $46 million in bonus payments for employees of Purdue Pharma, but held off considering a $1.3 million bonus for the company's CEO after hearing last-minute evidence of a $6 million payment made to him last year.

← Previous
…
7
8
9
10
11
12
13
14
15
Next →